Evren Technologies, Inc.
Evren Technologies is a bioelectronic medical device company focused on transforming the treatment of Post Traumatic Stress Disorder (PTSD) through non-invasive Vagal Nerve Stimulation (VNS) technologies. Their mission is to empower patients to rise above PTSD and improve their lives with innovative solutions.
Industries
Nr. of Employees
small (1-50)
Evren Technologies, Inc.
404 SW 140th Terrace, Suite 50, Newberry, FL 32669
Products
In-ear wearable transcutaneous auricular stimulation research system (programmable, home-capable)
A discreet in-ear stimulation system designed for laboratory and unsupervised home use with programmable stimulation, biosignal monitoring integration, data logging, remote communication, and adherence tracking.
In-ear wearable transcutaneous auricular stimulation research system (programmable, home-capable)
A discreet in-ear stimulation system designed for laboratory and unsupervised home use with programmable stimulation, biosignal monitoring integration, data logging, remote communication, and adherence tracking.
Expertise Areas
- Neuromodulation device development
- Transcutaneous auricular vagus nerve stimulation research
- Closed-loop adaptive neuromodulation
- In-ear wearable medical device design
Key Technologies
- Transcutaneous auricular vagus nerve stimulation (taVNS)
- In-ear wearable neuromodulation hardware
- Programmable electrical stimulation and waveform control
- Closed-loop adaptive stimulation algorithms
Key People
Founder and Chairman of the Board
CEO, President and Inside Director
Chief Technology Officer
Chief Financial Officer
Director of Operations
Chair of Patient Advisory Committee
Founder and Chairman of the Board
CEO, President and Inside Director
Chief Technology Officer
Chief Financial Officer
Director of Operations
Chair of Patient Advisory Committee
Investors
Seed Round - Evren Technologies
Announced on 2021-05-11.
Seed Round - Evren Technologies
Announced on 2020-01-01.
Seed Round - Evren Technologies
Announced on 2021-05-11.
Seed Round - Evren Technologies
Announced on 2020-01-01.
News & Updates
Evren Technologies has been accepted into the FDA’s Pilot TAP Program, which supports innovative medical devices.
Rick Giancola, a veteran in the life sciences industry, has joined the board of directors at Evren Technologies.
Rick Giancola has been appointed as the President of Evren Technologies, Inc.
Evren Technologies has launched the Phoenix CR, a state-of-the-art transcutaneous auricular vagus nerve stimulator for research purposes.
Evren Technologies received FDA Breakthrough Device Designation for the Phoenix, facilitating its development and review process.
Evren Technologies has been accepted into the FDA’s Pilot TAP Program, which supports innovative medical devices.
Rick Giancola, a veteran in the life sciences industry, has joined the board of directors at Evren Technologies.
Rick Giancola has been appointed as the President of Evren Technologies, Inc.
Evren Technologies has launched the Phoenix CR, a state-of-the-art transcutaneous auricular vagus nerve stimulator for research purposes.
Evren Technologies received FDA Breakthrough Device Designation for the Phoenix, facilitating its development and review process.